Successful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report

BACKGROUND: Ulcerative colitis is a lifelong, immunologically mediated disease. Direct-acting antivirals (DAAs) are now available for the treatment of chronic hepatitis C virus (HCV) infection. An interferon-free regimen appears useful, safe and effective for many patients for whom interferon-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohta, Yuki, Kanda, Tatsuo, Katsuno, Tatsuro, Yasui, Shin, Haga, Yuki, Sasaki, Reina, Nakamura, Masato, Wu, Shuang, Nakamoto, Shingo, Arai, Makoto, Yokosuka, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940930/
https://www.ncbi.nlm.nih.gov/pubmed/27401874
http://dx.doi.org/10.1186/s12876-016-0480-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940930/
https://www.ncbi.nlm.nih.gov/pubmed/27401874
http://dx.doi.org/10.1186/s12876-016-0480-x

Ejemplares similares